CA AR58

Assembly urges California Health and Human Services Agency to hold pharmaceutical companies, distributors, and pharmacies accountable for actions to address the current ADHD medication shortage and prevent future shortages

Assembly calls on California Health and Human Services Agency to urgently meet with U.S. Department of Health and Human Services and the federal Drug Enforcement Agency regarding modification of DEA quotas on ingredients needed to manufacture ADHD medications

Resolution identifies critical shortage of ADHD medications as an urgent mental health crisis causing harm to children, adults, and communities through behavioral regression, job performance decline, and increased substance abuse and mental health comorbidities

Resolution notes the DEA has declined to increase supply quotas despite manufacturer requests and has presented no justification for maintaining current quota limits beyond unsubstantiated claims that manufacturers have sufficient materials